D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR 0.82% Market Closed
Market Cap: 1.2B MYR

Duopharma Biotech Bhd
Investor Relations

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Ariff bin Abdul Shatar
Group MD & Executive Director
No Bio Available
Mr. Wu Kong Chek CPA
Chief Financial Officer
No Bio Available
Mr. Wan Amir-Jeffery Bin Wan Abdul Majid
Chief Executive Officer of Group Operations
No Bio Available
Mr. Ibrahim Hussin Salleh
Chief Legal Officer & Group Company Secretary
No Bio Available
Sabrina Binti Haron
Chief Compliance Officer
No Bio Available
Mr. Krisnakumara Reddi
Chief Manufacturing & Sustainability Officer
No Bio Available
Mr. Shamsul Idham Bin A. Iahad
Chief Consumer Healthcare Officer
No Bio Available
Wan Ahmad Nizam Bin Wan Mohd. Salleh
Group Head of Risk Management & Integrity
No Bio Available
Priya Darshini Asokan
Chief Innovation Officer
No Bio Available

Contacts

Address
SELANGOR
Klang
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya
Contacts
+60333232759
duopharmabiotech.com
sparklesyt

See Also

Summary
DPHARMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
DPHARMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DPHARMA stock valuation using valuation multiples.
Wall Street Estimates
DPHARMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DPHARMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.